Future studies incorporating ChIP‐seq, ATAC‐seq, and transcription factor knockdown experiments across multiple cell lines representing each breast cancer subtype would provide mechanistic insights into the differential regulation of LARP6 expression. This evidence concerns the gene LARP6 and breast carcinoma.